Michael Hertl

2.0k total citations
39 papers, 1.4k citations indexed

About

Michael Hertl is a scholar working on Pathology and Forensic Medicine, Rheumatology and Genetics. According to data from OpenAlex, Michael Hertl has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 17 papers in Rheumatology and 11 papers in Genetics. Recurrent topics in Michael Hertl's work include Autoimmune Bullous Skin Diseases (16 papers), Urticaria and Related Conditions (14 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers). Michael Hertl is often cited by papers focused on Autoimmune Bullous Skin Diseases (16 papers), Urticaria and Related Conditions (14 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers). Michael Hertl collaborates with scholars based in Germany, United States and Switzerland. Michael Hertl's co-authors include Lioba Büdinger, Hans F. Merk, Luca Borradori, Rüdiger Eming, Frank K. Jugert, Kim B. Yancey, Christina Yee, S. Ferenčík, H. Grosse‐Wilde and Thomas Hunziker and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Journal of Cell Science.

In The Last Decade

Michael Hertl

35 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hertl Germany 18 778 705 541 317 256 39 1.4k
Janice Canvin United Kingdom 17 898 1.2× 1.7k 2.5× 924 1.7× 331 1.0× 178 0.7× 36 2.4k
Aikaterini Patsatsi Greece 23 547 0.7× 364 0.5× 308 0.6× 676 2.1× 32 0.1× 126 1.6k
Snejina Vassileva Bulgaria 16 603 0.8× 442 0.6× 340 0.6× 211 0.7× 63 0.2× 57 975
A. Sparsa France 14 606 0.8× 533 0.8× 409 0.8× 215 0.7× 65 0.3× 66 1.1k
Silvia Mariel Ferrucci Italy 20 353 0.5× 394 0.6× 206 0.4× 401 1.3× 44 0.2× 92 1.2k
Shunsuke Takahagi Japan 14 195 0.3× 441 0.6× 211 0.4× 297 0.9× 45 0.2× 64 860
R. D. G. Peachey United Kingdom 19 380 0.5× 282 0.4× 103 0.2× 450 1.4× 47 0.2× 61 1.2k
Helmut Beltraminelli Switzerland 18 442 0.6× 236 0.3× 153 0.3× 466 1.5× 79 0.3× 60 1.1k
Daniele Torchia Italy 17 252 0.3× 338 0.5× 44 0.1× 381 1.2× 260 1.0× 72 1.0k
Hamidreza Mahmoudi Iran 19 594 0.8× 314 0.4× 347 0.6× 326 1.0× 25 0.1× 129 1.2k

Countries citing papers authored by Michael Hertl

Since Specialization
Citations

This map shows the geographic impact of Michael Hertl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hertl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hertl more than expected).

Fields of papers citing papers by Michael Hertl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hertl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hertl. The network helps show where Michael Hertl may publish in the future.

Co-authorship network of co-authors of Michael Hertl

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hertl. A scholar is included among the top collaborators of Michael Hertl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hertl. Michael Hertl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santos, Antônio Carlos dos, et al.. (2025). Deep Analysis of Desmoglein-3–Reactive CD4+ T Cells in Pemphigus Vulgaris Reveals a Type 17/Type 2 T-Cell Signature. Journal of Investigative Dermatology. 146(4). 973–985.e6.
2.
Waschke, Jens, Masayuki Amagai, Christoph Becker, et al.. (2025). Meeting report – Alpine desmosome disease meeting 2024: advances and emerging topics in desmosomes and related diseases. Journal of Cell Science. 138(2). 1 indexed citations
3.
Didona, Dario, Katharina Meier, Roberto Maglie, et al.. (2024). Pathogenic relevance of antibodies against desmoglein 3 in patients with oral lichen planus. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(10). 1392–1399. 3 indexed citations
4.
Hertl, Michael, et al.. (2015). Molekulare Diagnostik der blasenbildenden Autoimmundermatosen. Der Hautarzt. 67(1). 33–39. 8 indexed citations
5.
Beissert, Stefan & Michael Hertl. (2015). Autoimmundermatosen. Der Hautarzt. 66(8). 572–573. 1 indexed citations
6.
Horváth, Barbara, A. Niedermeier, Eva Podstawa, et al.. (2010). IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis. Experimental Dermatology. 19(7). 648–653. 36 indexed citations
7.
Hertl, Michael, Frank K. Jugert, & Hans F. Merk. (2006). CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. British Journal of Dermatology. 132(2). 215–220. 23 indexed citations
8.
Eming, Rüdiger & Michael Hertl. (2006). Autoimmune bullous disorders. Clinical Chemistry and Laboratory Medicine (CCLM). 44(2). 144–9. 13 indexed citations
9.
Hertl, Michael. (2006). T cell control in autoimmune bullous skin disorders. Journal of Clinical Investigation. 116(5). 1159–1166. 146 indexed citations
10.
Hofmann, Silke, Sybille Thoma-Uszynski, Gerold Schuler, et al.. (2002). Severity and Phenotype of Bullous Pemphigoid Relate to Autoantibody Profile Against the NH2- and COOH-Terminal Regions of the BP180 Ectodomain. Journal of Investigative Dermatology. 119(5). 1065–1073. 145 indexed citations
11.
Hertl, Michael, et al.. (2001). Characterization of T Cell Responses to Fragrances. Toxicology and Applied Pharmacology. 172(3). 172–178. 36 indexed citations
13.
Hertl, Michael, et al.. (2001). Das hepatorenale Syndrom. Der Internist. 42(12). 1666–1673. 3 indexed citations
14.
Büdinger, Lioba, et al.. (2001). Preferential Usage of TCR-Vβ17 by Peripheral and Cutaneous T Cells in Nickel-Induced Contact Dermatitis. The Journal of Immunology. 167(10). 6038–6044. 33 indexed citations
15.
Sachs, Bernhardt, Michael Hertl, & Hans F. Merk. (2000). Histamine Receptors on Lymphocytes: Distribution and Functional Significance. Skin Pharmacology and Physiology. 13(6). 313–323. 14 indexed citations
16.
Büdinger, Lioba & Michael Hertl. (2000). Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview. Allergy. 55(2). 108–115. 147 indexed citations
17.
Hertl, Michael. (2000). Humoral and Cellular Autoimmunity in Autoimmune Bullous Skin Disorders. International Archives of Allergy and Immunology. 122(2). 91–100. 80 indexed citations
18.
Jaunin, Fabienne, et al.. (1999). IgG Autoantibodies from Bullous Pemphigoid (BP) Patients Bind Antigenic Sites on Both the Extracellular and the Intracellular Domains of the BP Antigen 180. Journal of Investigative Dermatology. 112(2). 141–147. 90 indexed citations
19.
Hertl, Michael, Stefan Binder, Mosaad Megahed, G. Goerz, & Thomas Krieg. (1994). Gemeinsames Auftreten einer extraabdominellen Fibromatose und posttraumatischer Keloide. Der Hautarzt. 45(2). 113–116. 3 indexed citations
20.
Hertl, Michael, David R. Kaplan, John D. Fayen, et al.. (1991). The accessory function of B lymphocytes is resistant to the adverse effects of UV radiation. European Journal of Immunology. 21(2). 291–297. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026